Skip to content

Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test

Linguistic Adaptation of Rhinitis Control Assessment Test (RCAT) in Korean and Responsiveness to Disease Severity, Quality of Life, and Treatment in Adult Rhinitis Patients: A Multicenter Prospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02279706
Acronym
R-CAT
Enrollment
130
Registered
2014-10-31
Start date
2014-10-31
Completion date
2015-10-31
Last updated
2016-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinitis

Brief summary

Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT).

Detailed description

Check the Korean version of rhinitis controlled assessment tests, the total non-symptom scores (total nasal symptoms score, TNSS), rhinitis-related quality of life (RQLQ), rhinitis controlled degree, severity, and after study enrollment and 4 weeks treatment.

Interventions

OTHERquestionnaire

Check the Korean version of rhinitis controlled assessment tests, the total non-symptom scores (total nasal symptoms score, TNSS), rhinitis-related quality of life (RQLQ), rhinitis controlled degree, severity, and after study enrollment and 4 weeks treatment.

Sponsors

Ajou University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults over 19 years 2. Past medical history and allergy skin test or who have been diagnosed with allergic or non-allergic rhinitis, based on serum specific immunoglobulin E . 3. People who have experienced symptoms of rhinitis within 12 months from the time of study enrollment. 4. People who have rhinitis symptoms requiring medication at the time of study enrollment. 5. People who can read and write korea language. 6. People who signed a written consent form approved by the Institutional Review Board of their respective organizations to participate in this study freely hearing to explain fully the purpose for the contents of this study prior to participation in research.

Exclusion criteria

1. People diagnosed with Rhinitis medicamentosa. 2. People determined that bacterial or viral respiratory infection at the time of study enrollment. 3. People who have evidence of nasal infection 4. People associated anatomical abnormality that causes severe nasal congestion as deviation of nasal septum. 5. People determined that acute or chronic sinusitis according to the researchers determined. 6. In case that pregnancy test is positive, or ambiguous conclusions among female patients. 7. people deemed unsuitable for clinical trial participation due to other reasons.

Design outcomes

Primary

MeasureTime frameDescription
Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT)up to 4weeksCheck the Korean version of rhinitis controlled assessment tests

Secondary

MeasureTime frameDescription
rhinitis-related quality of lifeup to 4weeksrhinitis-related quality of life (RQLQ)check up to 24 weeks

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026